Identifying and interpreting actionable molecular alterations from next-generation sequencing results in the community: A Sarah Cannon molecular cancer conference.
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2018.36.15_suppl.6601
Abstract: 6601Background: Next-generation sequencing (NGS) data can often be difficult to interpret and act upon for treating medical oncologists. Sarah Cannon developed a Molecular Cancer Conference (MCC) i... read more here.
Keywords: cancer conference; sarah cannon; molecular cancer; next generation ... See more keywords